Our analysis revealed that the five unique hub genes (PPARG, HIPK2, ZFP36L1, HMGB2 and ALDH1A3) may constitute a gene expression signature specifying a therapeutic response of ERβ1-expressing ERα-positive breast cancer cells to treatment with OHT+ATRA. This evidence concerns the gene HMGB2 and breast carcinoma.